Key result
Trypanosoma cruzi rapidly migrates across endothelial cells without disrupting monolayer integrity, a process facilitated by bradykinin and augmented by CCL2.
T. cruzi can actively migrate across intact endothelial monolayers via a novel mechanism distinct from leukocyte transmigration, offering new insights into parasite dissemination in Chagas disease.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for T. cruzi dissemination in Chagas; human relevance and therapeutic targeting remain untested.
Chagas heart disease, the leading cause of heart failure in Latin America, results from infection with the parasite Trypanosoma cruzi. Although T. cruzi disseminates intravascularly, how the parasite contends with the endothelial barrier to escape the bloodstream and infect tissues has not been described. Understanding the interaction between T. cruzi and the vascular endothelium, likely a key step in parasite dissemination, could inform future therapies to interrupt disease pathogenesis. We adapted systems useful in the study of leukocyte transmigration to investigate both the occurrence of parasite transmigration and its determinants in vitro. Here we provide the first evidence that T. cruzi can rapidly migrate across endothelial cells by a mechanism that is distinct from productive infection and does not disrupt monolayer integrity or alter permeability. Our results show that this process is facilitated by a known modulator of cellular infection and vascular permeability, bradykinin, and can be augmented by the chemokine CCL2. These represent novel findings in our understanding of parasite dissemination, and may help identify new therapeutic strategies to limit the dissemination of the parasite.
No takes yet. Share an insight, caveat, or question.
Coates et al. (2013) studied Chagas disease. Trypanosoma cruzi vs. Uninfected cells or inhibitor-treated cells was evaluated on Transendothelial migration. Trypanosoma cruzi rapidly migrates across endothelial cells without disrupting monolayer integrity, a process facilitated by bradykinin and augmented by CCL2.
Synapse has enriched 10 related papers. Consider them for comparative context: